You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pf-04449913

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • PF-04449913
  • +5 more
  • Nagoya, Aichi, Japan
  • +8 more
Jan 12, 2022

Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

Completed
Has Results
  • Adult Acute Myeloid Leukemia in Remission
  • Recurrent Adult Acute Myeloid Leukemia
  • PF-04449913
  • Aurora, Colorado
  • +1 more
Dec 30, 2021

Glioblastoma Trial in Spain (PF-04449913, Temozolomide Oral Capsule)

Active, not recruiting
  • Glioblastoma
  • PF-04449913
  • Temozolomide Oral Capsule
  • Badalona, Barcelona, Spain
  • +7 more
Feb 16, 2022

Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa (PF-04449913)

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • Chronic Myelomonocytic Leukemia (CMML)
  • PF-04449913
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 10, 2021

Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)

Completed
Has Results
  • Acute Myeloid Leukemia
  • PF-04449913
  • +4 more
  • Birmingham, Alabama
  • +80 more
Feb 19, 2020

Hematologic Malignancies Trial in Italy, United States (PF-04449913)

Completed
  • Hematologic Malignancies
  • PF-04449913
  • La Jolla, California
  • +5 more
Dec 8, 2013

Solid Tumors Trial in Los Angeles, Aurora, Boston (PF-04449913)

Completed
  • Solid Tumors
  • PF-04449913
  • Los Angeles, California
  • +2 more
Jun 5, 2013